This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Müller-Bardorff, M. Articles by Katus, H. A. Search for Related Content PubMed PubMed Citation Articles by Müller-Bardorff, M. Articles by Katus, H. A. Pubmed/NCBI databases Medline Plus Health Information Heart Attack

(Circulation. 1995;92:2869-2875.)
© 1995 American Heart Association, Inc.

Articles

Development and Characterization of a Rapid Assay for Bedside Determinations of Cardiac Troponin T

Margit Müller-Bardorff, MD; Helmut Freitag, PhD; Thomas Scheffold, MD; Andrew Remppis, MD; Wolfgang Kübler, MD; Hugo A. Katus, MD

From the Medizinische Universitätsklinik (M.M.-B., H.A.K., T.S., A.R., W.K.), Abteilung Innere Medizin III, Heidelberg; and Boehringer Mannheim GmbH (H.F.), Mannheim, Germany.

Correspondence to Hugo A. Katus, MD, Medizinische Universitätsklinik, Abtlg Innere Medizin III, Bergheimer Str 58, 69115 Heidelberg, Germany.

Background The appearance of cardiac proteins in blood is the most specific and sensitive indicator of acute myocardial cell necrosis. The measurement of cardiac markers, however, is time consuming and requires sophisticated equipment. To facilitate the biochemical detection for acute myocardial cell necrosis, a whole-blood rapid assay device for cardiac troponin T detection was developed that provides a test result within 20 minutes.

Methods and Results Monoclonal antibody M7 is labeled with gold particles, and antibody 1B10 is labeled with biotin. Both antibodies, as well as buffer substances and detergents, are adsorbed onto paper fleeces mounted below an application well. Heparinized blood (160 µL) applied to this well solubilizes the dry chemistry reagents. Blood cells are separated from plasma via a glass-fiber fleece. The immunocomplexes formed are concentrated within the reading zone by binding of the biotin-labeled antibody with streptavidine immobilized to the test device. Troponin T bound to the test device serves as a control. The detection limit of this assay is 0.18 µg/L with a cross-reactivity with skeletal troponin T of 0.5%. In clinical analyses involving 25 healthy volunteers, 62 patients with chest pain but without myocardial ischemia, 35 patients with acute myocardial infarction, 24 patients with minor myocardial cell damage due to radiofrequency ablation, and 35 patients with unstable angina, the rapid assay was comparable to the troponin T enzyme immunoassay in regard to sensitivity and specificity.

Conclusions This newly developed assay allows accurate, rapid, and convenient diagnosis of acute myocardial cell necrosis.

Key Words: infarction • tests • cardiac troponin T

This article has been cited by other articles:

				C. W. Hamm, H. Möllmann, J.-P. Bassand, and F. van de Werf CHAPTER 16 Acute Coronary Syndromes ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]

				S. B. Rosalki, R. Roberts, H. A. Katus, E. Giannitsis, J. H. Ladenson, and F. S. Apple Cardiac Biomarkers for Detection of Myocardial Infarction: Perspectives from Past to Present Clin. Chem., November 1, 2004; 50(11): 2205 - 2213. [Abstract] [Full Text] [PDF]

				E. Giannitsis, M. Muller-Bardorff, V. Kurowski, B. Weidtmann, U. Wiegand, M. Kampmann, and H. A. Katus Independent Prognostic Value of Cardiac Troponin T in Patients With Confirmed Pulmonary Embolism Circulation, July 11, 2000; 102(2): 211 - 217. [Abstract] [Full Text] [PDF]

				C. W. Hamm and E. Braunwald A Classification of Unstable Angina Revisited Circulation, July 4, 2000; 102(1): 118 - 122. [Abstract] [Full Text] [PDF]

				C. Heeschen, B.U. Goldmann, W. Terres, and C.W. Hamm Cardiovascular risk and therapeutic benefit of coronary interventions for patients with unstable angina according to the troponin T status Eur. Heart J., July 2, 2000; 21(14): 1159 - 1166. [Abstract] [PDF]

				C. R. deFilippi, M. Tocchi, R. J. Parmar, S. Rosanio, G. Abreo, M. A. Potter, M. S. Runge, and B. F. Uretsky Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: angiographic correlates and long-term clinical outcomes J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1827 - 1834. [Abstract] [Full Text] [PDF]

				D. A. Morrow, N. Rifai, E. M. Antman, D. L. Weiner, C. H. McCabe, C. P. Cannon, and E. Braunwald Serum amyloid A predicts early mortality in acute coronary syndromes: a TIMI 11A substudy J. Am. Coll. Cardiol., February 1, 2000; 35(2): 358 - 362. [Abstract] [Full Text] [PDF]

				M. Muller-Bardorff, T. Rauscher, M. Kampmann, S. Schoolmann, F. Laufenberg, D. Mangold, R. Zerback, A. Remppis, and H. A. Katus Quantitative Bedside Assay for Cardiac Troponin T: A Complementary Method to Centralized Laboratory Testing Clin. Chem., July 1, 1999; 45(7): 1002 - 1008. [Abstract] [Full Text] [PDF]

				C. W. Hamm, B. U. Goldmann, C. Heeschen, G. Kreymann, J. Berger, and T. Meinertz Emergency Room Triage of Patients with Acute Chest Pain by Means of Rapid Testing for Cardiac Troponin T or Troponin I N. Engl. J. Med., December 4, 1997; 337(23): 1648 - 1653. [Abstract] [Full Text] [PDF]

				A S Wierzbicki and T M Reynolds Cardiac troponin T in unstable angina BMJ, November 23, 1996; 313(7068): 1330a - 1330. [Full Text]